US FDA’s Remote Evaluations Of Drug Manufacturing Facilities May Become Public
Agency is considering posting its observations from remote assessments of facilities, assistant commissioner Miller tells annual FDLI meeting; new FDA Inspectional Activities Council will develop an action plan for the agency’s inspections program.
You may also be interested in...
US FDA 'resilience' report charts how inspection backlog grew and impacted approvals and compliance follow-up.
Time taken for interagency alignment, lessons learned from foreign counterparts will increase use of remote video tours, say FDA officials..
Video facility tours expected to help clear way for timely drug and biologic approvals while COVID-19 still prevents inspections.